Del. Judge Invalidates Stanford Kidney Test Patents
A Delaware federal judge has determined that three Stanford University patents licensed to a developer of commercial tests for kidney transplant rejections are invalid, finding the claims at issue weren't eligible...To view the full article, register now.
Already a subscriber? Click here to view full article